Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity
Author:
Poynard ThierryORCID,
Deckmyn Olivier,
Munteanu Mona,
Ngo Yen,
Drane Fabienne,
Castille Jean Marie,
Housset Chantal,
Ratziu Vlad
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. EVOLUTION OF FIBROSIS, INFLAMMATION, STEATOSIS AND STEATOHEPATITIS IN HCV INFECTED PATIENTS AFTER TREATMENT WITH DIRECT- ACTING ANTIVIRAL THERAPY (A FIBROMAX® ANALYSIS);Archiv Euromedica;2022-12-20
2. Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19;Biomedicines;2022-03-17
3. External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B;Gastro Hep Advances;2022
4. External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV;JHEP Reports;2021-08
5. Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices;Alimentary Pharmacology & Therapeutics;2020-06-29